Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
MINDACT long-term results: 70-gene signature MammaPrint to guide adjuvant chemot...
Dr Fatima Cardoso - Champalimaud Clinical Center, Lisbon, Portugal
MINDACT long-term results: 70-gene signature MammaPrint to guide adjuvant chemotherapy use in breast cancer ( Dr Fatima Cardoso - Champalimaud Clinical Center, Lisbon, Portugal )
18 Jun 2020
Maintenance treatment in multiple myeloma: A new era
Prof Sagar Lonial and Prof Wee-Joo Chng
Maintenance treatment in multiple myeloma: A new era ( Prof Sagar Lonial and Prof Wee-Joo Chng )
18 Jun 2020
Preclinical models for small-cell lung cancer
Prof Anton Berns - Netherlands Cancer Institute, Amsterdam, Netherlands
Preclinical models for small-cell lung cancer ( Prof Anton Berns - Netherlands Cancer Institute, Amsterdam, Netherlands )
18 Jun 2020
Conducting Oncology Clinical Trials in Africa II: Regulatory Process for Clinica...
Mr Dennis Ake, MSc.
Conducting Oncology Clinical Trials in Africa II: Regulatory Process for Clinical Trials in Africa ( Mr Dennis Ake, MSc. )
18 Jun 2020
Early safety from a trial of talimogene laherparepvec (T-VEC) injected into live...
Prof J. Randy Hecht - UCLA Jonsson Comprehensive Cancer Center, Santa Monica, US...
Early safety from a trial of talimogene laherparepvec (T-VEC) injected into liver tumours plus pembrolizumab ( Prof J. Randy Hecht - UCLA Jonsson Comprehensive Cancer Center, Santa Monica, USA )
17 Jun 2020
CITYSCAPE: Tiragolumab plus atezolizumab for non-small cell lung cancer
Dr Melissa Johnson - Sarah Cannon Research Institute, Nashville, USA
CITYSCAPE: Tiragolumab plus atezolizumab for non-small cell lung cancer ( Dr Melissa Johnson - Sarah Cannon Research Institute, Nashville, USA )
17 Jun 2020
Phase II data from the KarMMa trial for relapsed/refractory multiple myeloma
Dr Nikhil Munshi - Dana Farber Cancer Institute, Boston, USA
Phase II data from the KarMMa trial for relapsed/refractory multiple myeloma ( Dr Nikhil Munshi - Dana Farber Cancer Institute, Boston, USA )
16 Jun 2020
Conducting Oncology Clinical Trials in Africa II: Twitter Workshop
Runcie C.W. Chidebe - Executive Director, Project PINK BLUE
Conducting Oncology Clinical Trials in Africa II: Twitter Workshop ( Runcie C.W. Chidebe - Executive Director, Project PINK BLUE )
16 Jun 2020
Pembrolizumab vs brentuximab vedotin in relapsed or refractory classic Hodgkin l...
Dr John Kuruvilla - Princess Margaret Cancer Centre, Toronto, Canada
Pembrolizumab vs brentuximab vedotin in relapsed or refractory classic Hodgkin lymphoma ( Dr John Kuruvilla - Princess Margaret Cancer Centre, Toronto, Canada )
16 Jun 2020
FGFR inhibitors in bladder cancer: Testing, screening and highlights from ASCO 2...
Prof Robert Huddart and Dr Ignacio Durán
FGFR inhibitors in bladder cancer: Testing, screening and highlights from ASCO 2020 ( Prof Robert Huddart and Dr Ignacio Durán )
15 Jun 2020
Perioperative chemotherapy with mFOLFIRINOX vs gemcitabine/nab-paclitaxel for re...
Prof Davendra Sohal - University of Cincinnati, Cincinnati, USA
Perioperative chemotherapy with mFOLFIRINOX vs gemcitabine/nab-paclitaxel for resectable pancreatic ductal adenocarcinoma ( Prof Davendra Sohal - University of Cincinnati, Cincinnati, USA )
15 Jun 2020
High-dose twice daily thoracic radiotherapy in limited disease small-cell lung c...
Prof Bjørn Henning Grønberg - Trondheim University Hospital, Trondheim, Norway
High-dose twice daily thoracic radiotherapy in limited disease small-cell lung cancer ( Prof Bjørn Henning Grønberg - Trondheim University Hospital, Trondheim, Norway )
15 Jun 2020